share_log

HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $15

HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $15

HC Wainwright & Co.維持對Addex Therapeutics的買入,將目標價下調至15美元
Benzinga Real-time News ·  2022/05/31 06:28

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Addex Therapeutics (NASDAQ:ADXN) with a Buy and lowers the price target from $21 to $15.

HC Wainwright & Co. 分析師拉古拉姆·塞爾瓦拉朱維持Addex Therapeutics(納斯達克股票代碼:ADXN)的買入,並將目標股價從21美元下調至15美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論